Stay updated on Defactinib and VS-6766 in Uveal Melanoma Clinical Trial
Sign up to get notified when there's something new on the Defactinib and VS-6766 in Uveal Melanoma Clinical Trial page.

Latest updates to the Defactinib and VS-6766 in Uveal Melanoma Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedRevision tag updated from v3.6.4 to v3.6.5, signaling a new page version. The change affects only metadata and does not alter the study information displayed.SummaryDifference0.0%

- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedRevision label updated to v3.6.4, signaling a minor version update of the page template or content. It does not modify study details or user-facing information.SummaryDifference0.0%

- Check53 days agoChange DetectedThe page revision tag was updated from v3.6.2 to v3.6.3, signaling a minor backend/template update to the Study Details page.SummaryDifference0.0%

- Check60 days agoChange DetectedThe page shows a revision update from v3.6.0 to v3.6.2, indicating a small backend/template update that does not change the study information presented to users.SummaryDifference0.0%

- Check74 days agoChange DetectedThe page now indicates enrollment has stopped early and no participants are being sought, reflecting a terminated trial. It also adds quick-access sections such as 'No longer looking for participants,' 'How to Read a Study Record,' 'Common Questions,' and 'How to Join a Study,' along with a revision tag updated to v3.6.0.SummaryDifference0.5%

- Check81 days agoChange DetectedThe page revision has been updated from v3.5.4 to v3.5.5, indicating a deployment update. This does not modify the study details or other user-facing content.SummaryDifference0.0%

Stay in the know with updates to Defactinib and VS-6766 in Uveal Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Defactinib and VS-6766 in Uveal Melanoma Clinical Trial page.